HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Combination of p53AIP1 and survivin expression is a powerful prognostic marker in non-small cell lung cancer.

AbstractBACKGROUND:
p53AIP1 is a potential mediator of apoptosis depending on p53, which is mutated in many kinds of carcinoma. High survivin expression in non-small cell lung cancer is related with poor prognosis. To investigate the role of these genes in non-small cell lung cancer, we compared the relationship between p53AIP1 or survivin gene expression and the clinicopathological status of lung cancer.
MATERIALS AND METHODS:
Forty-seven samples from non-small cell lung cancer patients were obtained between 1997 and 2003. For quantitative evaluation of RNA expression by PCR, we used Taqman PCR methods.
RESULTS:
Although no correlation between p53AIP1 or survivin gene expression and clinicopathological factors was found, the relationship between survivin gene expression and nodal status was significant (p = 0.03). Overall survival in the p53AIP1-negative group was significantly worse than in the positive group (p = 0.04); however, although survivin expression was not a prognostic factor, the combination of p53AIP1 and survivin was a significant prognostic predictor (p = 0.04). In the multivariate cox proportional hazard model, the combination was an independent predictor of overall survival (p53AIP1 (+) survivin (+), HR 0.21, 95%CI = [0.01-1.66]; p53AIP1 (+) survivin (-), HR 0.01, 95%CI = [0.002-0.28]; p53AIP1 (-) survivin (-), HR 0.01, 95%CI = [0.002-3.1], against p53AIP1 (-) survivin (+), p = 0.03).
CONCLUSION:
These data suggest that the combination of p53AIP1 and survivin gene expression may be a powerful tool to stratify subgroups with better or worse prognosis from the variable non-small cell lung cancer population.
AuthorsShin-ichi Yamashita, Masao Chujo, Michiyo Miyawaki, Keita Tokuishi, Kentaro Anami, Satoshi Yamamoto, Katsunobu Kawahara
JournalJournal of experimental & clinical cancer research : CR (J Exp Clin Cancer Res) Vol. 28 Pg. 22 (Feb 19 2009) ISSN: 1756-9966 [Electronic] England
PMID19228369 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Apoptosis Regulatory Proteins
  • Biomarkers, Tumor
  • P53AIP1 protein, human
Topics
  • Adult
  • Aged
  • Apoptosis Regulatory Proteins (biosynthesis, genetics)
  • Biomarkers, Tumor (biosynthesis, genetics)
  • Carcinoma, Non-Small-Cell Lung (genetics, metabolism, pathology)
  • Female
  • Gene Expression
  • Genes, p53
  • Humans
  • Lung Neoplasms (genetics, metabolism, pathology)
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Prognosis
  • Survival Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: